Novel Immunoassay Platform for Evaluating Multiple Analytes with Minimal Sample Volume The quantitative analysis of cytokines and other analytes in plasma, serum, or cell lysate is becoming ...
As an original manufacturer, Cloud-Clone redefines lab efficiency with high-sensitivity multiplex kits, offering a ...
Group B Streptococcus (GBS) is a Gram positive coccus which is part of the normal microbiota of the GI and GU tracts. However GBS is also a major cause of septicaemia and meningitis in newborns.
The NMI applies miniaturized multiplex immunoassays for more than two decades. At the NMI commercially available multiplex immunoassays are applied for sample screening as well as newly developed ...
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
The Centers for Disease Control and Prevention estimates that one in every four deaths in the United States is due to cancer, yet approximately one-third of all cancer cases could be prevented if ...
Multiplex Assays Market to be Worth $6.80 Billion by 2031 - Exclusive Report by Meticulous Research®
REDDING, Calif., Aug. 6, 2024 /PRNewswire/ -- According to a new market research report titled, 'Multiplex Assays Market Size, Share, Forecast, & Trends Analysis by Type (Protein [Bead, Planar], ...
Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...
How do you multiplex an immunoassay? There are two main ways of multiplexing an immunoassay; by separating the individual assays into different spaces (spatial separation) or by immobilizing ...
This approach delivers world-class research tools at an accessible cost for global researchers, breaking the foreign monopoly in high-end multiplex detection. Today, Cloud-Clone’s multiplex assay kits ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results